TuesdayDec 06, 2016 5:00 pm

CV Sciences (CVSI) Starts Presentation at LD Micro Main Event

CV Sciences (OTC: CVSI) is a life science company focused on developing and commercializing novel therapeutics utilizing synthetic Cannabidiol (CBD). The company operates through two segments: specialty pharmaceutical and consumer product. It also manufactures, markets and sells plant-based CBD products under PlusCBD brand for a range of market sectors, including nutraceutical, beauty care, specialty foods and vape. For more information, visit the company's website at www.cvsciences.com. About CBDWire CBDWire (CBDW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of…

Continue Reading

TuesdayDec 06, 2016 3:00 pm

Psychemedics (PMD) Starts Presentation at LD Micro Main Event

Psychemedics (NASDAQ: PMD) provides testing services for the detection of drugs of abuse through the analysis of hair samples. The company's tests provide quantitative information that can indicate the approximate amount of drug ingested, as well as historical data, which can show a pattern of individual drug use over a longer period of time. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, PCP, amphetamines and opiates. Its services are addressed to employers for applicant and employee testing, treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. For…

Continue Reading

TuesdayDec 06, 2016 10:57 am

Singlepoint, Inc. (SING) Offers Update on Corporate Initiatives Related to SingleSeed Subsidiary

Before the opening bell, Singlepoint, Inc. (OTC: SING) issued an update on the corporate initiatives being taken by its SingleSeed subsidiary in order to better position itself in the growing domestic cannabis industry. Following November’s vote, more than half of all U.S. states have now legalized marijuana for either recreational or medicinal purposes, leading to a figurative ‘green rush’ comprised of businesses seeking to capitalize on the emergence of the industry. SingleSeed, in particular, is focused on providing improved access to electronic payment options for dispensaries and similar businesses. Although banking is currently highly restricted based on federal regulations regarding…

Continue Reading

MondayDec 05, 2016 12:27 pm

Singlepoint (SING) Subsidiary Looks to Help Cannabis Merchants Build Trust, Increase Customer Loyalty

A leading provider of mobile technology and mobile payment solutions serving various markets and industries, Singlepoint, Inc. (OTC: SING) has its eyes set on the fast-growing cannabis industry, aiming to help legal marijuana businesses build trust and increase customer loyalty via subsidiary SingleSeed and its highly reliable payment processing and marketing tools. With eight more states voting to legalize either medical or recreational marijuana use last month, the marijuana industry is set to exceed $7 billion this year and to reach roughly $20 billion by 2020. However, legal businesses operating in the sector still find it hard to obtain support…

Continue Reading

FridayDec 02, 2016 3:44 pm

Singlepoint, Inc. (SING) CEO Discusses Influx of Calls from Cannabis Dispensaries on MoneyTV with Donald Baillargeon

Before the opening bell, Singlepoint, Inc. (OTC: SING) was announced as a featured company on this week’s episode of MoneyTV with Donald Baillargeon. MoneyTV is an internationally syndicated television program about “money and what makes it happen.” The show includes informative interviews with company CEOs, offering prospective investors insight into their operations and outlooks for the future. To view this week’s program, visit www.MoneyTV.net In the interview, Greg Lambrecht, chief executive officer of Singlepoint, offered prospective investors an update on the progress of the company’s SingleSeed subsidiary, which it awakened from a quiet period in early November in an effort…

Continue Reading

MondayNov 28, 2016 3:33 pm

Corbus Pharmaceuticals Holdings, Inc. (CRBP) is “One to Watch”

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP), a clinical stage drug development company targeting rare, chronic, and serious inflammatory and fibrotic diseases, recently reported its third quarter financial results (http://nnw.fm/ewaP8) for the three months ended September 30, 2016. CRBP reported a net loss for the third quarter due to increased spending on clinical studies for systemic sclerosis and CF, plus increased staffing costs, bonuses, and other expenditures. However, the company ended the third quarter with just under $19 million in cash and cash equivalents, which it believes to be sufficient to meet its operating and capital requirements through the end of…

Continue Reading

WednesdayNov 23, 2016 11:14 am

Singlepoint, Inc. (SING) Leveraging Its Existing Foothold to Be a First Mover in California’s Cannabis Industry

With voters in California having passed the Election Day ballot initiative to legalize marijuana for recreational purposes, estimates released in The Marijuana Business Daily (http://nnw.fm/mAY9j) reported that California’s recreational marijuana industry could eventually generate anywhere between $4.5 and $5 billion in annual retail sales. The article states that, in addition to enabling California to reclaim its mantle as the capital of the cannabis trade, it would also position the state as the most attractive market for business opportunities. Proposition 64 now enables adults aged 21 and over to use and possess an ounce or less of marijuana for nonmedical purposes.…

Continue Reading

ThursdayNov 17, 2016 12:54 pm

Singlepoint, Inc. (SING) Subsidiary SingleSeed Aiming to Help Cannabis Business Owners Thrive

The U.S. cannabis market is expected to continue and even speed up its exponential growth as a result of last week’s vote to legalize recreational or medical marijuana in eight more states. This is good news for an industry that is already growing at a fast pace, being set to exceed $7 billion this year, according to ArcView Research estimates. The trend is likely to continue, as experts predict the marijuana market to reach roughly $22 billion by 2020 and $50 billion by 2026. But even if the market is growing so quickly, legal businesses operating in the sector still…

Continue Reading

MondayNov 14, 2016 11:43 am

Singlepoint, Inc. (SING) Predicting Policy Changes for Newly-Expanded Marijuana Industry

Legalized cannabis, whether for recreational or medicinal purposes, is at the center of one of the nation’s most transformative industries. Since the passing of California’s Compassionate Use Act of 1996, which made the state the first in the country to legalize medical marijuana, states across the country have been reevaluating the federal government’s decision to outlaw cannabis. In 2012, Colorado and Washington state took another step toward the legalization of cannabis with Amendment 64 and Initiative 502, respectively. With these two measures, the first states in the Union approved the use of marijuana for recreational purposes. Since that vote, the…

Continue Reading

FridayNov 11, 2016 3:31 pm

Singlepoint, Inc. (SING) CEO Reflects on Impact of Election Day Results on MoneyTV with Donald Baillargeon

Before the opening bell, Singlepoint, Inc. (OTC: SING) was announced as a featured company on this week’s episode of MoneyTV with Donald Baillargeon. MoneyTV is an internationally syndicated television program about “money and what makes it happen.” The show includes informative interviews with company CEOs, offering prospective investors insight into their operations and outlooks for the future. To view this week’s program, visit www.MoneyTV.net In the interview, Greg Lambrecht, chief executive officer of Singlepoint, reflected on Tuesday’s polling results, particularly as they relate to the legalization of recreational and medicinal marijuana in states across the country. In total, four states…

Continue Reading

CBDWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000